Does Rallies show 13F holders for BTMD?

Yes. Rallies tracks hedge fund and 13F ownership data for BTMD, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BTMD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BTMD. It does not provide personalized investment advice.

BTMD (Biote Corp. Class A Common Stock) Stock Analysis - Hedge Fund Holdings

Biote Corp. Class A Common Stock (BTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, BTMD trades at $2.10 with a market cap of $57.93M and a P/E ratio of 4.28. BTMD moved +6.08% today. Year to date, BTMD is -14.98%; over the trailing twelve months it is -47.24%. Its 52-week range spans $1.27 to $6.98. Analyst consensus is strong buy with an average price target of $2.50. Rallies surfaces BTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BTMD stock?

Hedge funds tracked by Rallies that own BTMD include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biote Corp. Class A Common Stock.

BTMD Key Metrics

Key financial metrics for BTMD
Metric	Value
Price	$2.10
Market Cap	$57.93M
P/E Ratio	4.28
EPS	$0.49
Dividend Yield	0.00%
52-Week High	$6.98
52-Week Low	$1.27
Volume	8
Avg Volume	0
Revenue (TTM)	$188.16M
Net Income	$18.43M
Gross Margin	0.00%

Top Hedge Funds Holding BTMD

Exoduspoint Capital holds 41.56K shares of BTMD, changed +0.00% as of Sep 30, 2024.

Latest BTMD News

Biote Corp Q4 Revenue Falls 6.9% While Supplement Sales Rise 16% — Mar 12, 2026

Recent BTMD Insider Trades

Guines LLC bought 11.68K (~$39.11K) on May 7, 2025.
Guines LLC bought 436.04K (~$1.42M) on May 6, 2025.
Guines LLC bought 1.93K (~$6.37K) on Apr 30, 2025.

BTMD Analyst Consensus

4 analysts cover BTMD: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $2.50.

Common questions about BTMD

Who owns BTMD stock?: Hedge funds tracked by Rallies that own BTMD include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Biote Corp. Class A Common Stock.
Does Rallies show 13F holders for BTMD?: Yes. Rallies tracks hedge fund and 13F ownership data for BTMD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BTMD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BTMD. It does not provide personalized investment advice.